✦ LIBER ✦

A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

✍ Scribed by Cristina Gravalos, Antonieta Salut, Carlos García-Girón, Rocío García-Carbonero, Ana Isabel León, Isabel Sevilla, Joan Maurel, Beatriz Esteban, Eduardo García-Rico, Adolfo Murias, Hernán Cortés-Funes

Book ID: 118822745
Publisher: Springer Milan
Year: 2012
Tongue: Spanish
Weight: 294 KB
Volume: 14
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-012-0843-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine plus oxaliplatin (xelox) ve

Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial)

✍ Andrea Angelo Martoni; Carmine Pinto; Francesca Di Fabio; Giorgio Lelli; Fabiola 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 176 KB

A phase II study of biweekly oxaliplatin

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

✍ De Vita, F; Orditura, M; Matano, E; Bianco, R; Carlomagno, C; Infusino, S; Damia 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

A multicenter phase II clinical study of

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: A Japanese experience

✍ Hideo Baba; Naoko Hayashi; Yasunori Emi; Yoshihiro Kakeji; Akinori Egashira; Eij 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 143 KB

642 POSTER Cetuximab plus oxaliplatin/5-

642 POSTER Cetuximab plus oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) for the epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer (mCRC) in the first-line setting: a phase II study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 268 KB

A multicenter phase II clinical study of

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as second-line treatment for advanced colorectal cancer: A Japanese experience

✍ Yutaka Ogata; Shoji Tokunaga; Yasunori Emi; Eiji Oki; Hiroshi Saeki; Ken Shirabe 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 188 KB

Corrigendum to “Single-agent irinotecan

Corrigendum to “Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis” [Eur J Cancer 47 (12) (2011) 1826–1836]

✍ Stephen J. Clarke; Sonia Yip; Chris Brown; Guy A. van Hazel; David T. Ransom; Da 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 145 KB